G. T. Rogers

发表

Optimisation of small-scale coupling of A5B7 monoclonal antibody to carboxypeptidase G2.

J. Boyle, R. Melton, G. T. Rogers, 1993, Journal of immunological methods.

Extraction of CEA from tumour tissue, foetal colon and patients' sera, and the effect of perchloric acid.

G. T. Rogers, P. Keep, B. A. Leake, 1978, British Journal of Cancer.

Plasma clearance of an antibody--enzyme conjugate in ADEPT by monoclonal anti-enzyme: its effect on prodrug activation in vivo.

S. Sharma, G. T. Rogers, P. Burke, 1995, British Journal of Cancer.

Mapping epitope characteristics on carcinoembryonic antigen.

G. T. Rogers, P. Harwood, D. W. Britton, 1986, British Journal of Cancer.

United States Patent ( 19 ) Bagshawe et al . IIII USOO 5632990 A 11 Patent Number : 5 , 632 , 990 45 Date of Patent : 54 TREATMENT

G. T. Rogers, 2017 .

Effect of dose escalation of a monoclonal anti-CEA IgG on tumour localisation and tissue distribution in nude mice xenografted with human colon carcinoma

G. T. Rogers, R. Pedley, J. Boden, 2004, Cancer Immunology and Immunotherapy.

Limitations associated with the use of labelled antibodies against CEA for potential tumour localisation and therapy. A review.

G. T. Rogers, 1986, European journal of cancer & clinical oncology.

Studying cell death.

G. T. Rogers, R. Pedley, J. Boden, 1995, Environmental health perspectives.

Prolonged localisation of a monoclonal antibody against CEA in a human colon tumour xenograft.

G. T. Rogers, R. Pedley, J. Boden, 1985, British Journal of Cancer.

Preoperative carcinoembryonic antigen levels correlated with postoperative pathological staging in bronchial carcinoma.

G. T. Rogers, A. Kardana, K. Jeyasingham, 1980, Thorax.

Carcinoembryonic antigens and related glycoproteins. Molecular aspects and specificity.

G. T. Rogers, 1983, Biochimica et biophysica acta.

Immunological and chemical studies on sub-fractions of carcinoembryonic antigen.

G. T. Rogers, F. Searle, M. Wass, 1975, Immunochemistry.

Binding studies on two different monoclonal antibodies raised against CEA.

G. T. Rogers, A. Kardana, G. Rawlins, 1983, European journal of cancer & clinical oncology.

Heterogeneity of carcinoembryonic antigen. Implications on its role as a tumour marker substance.

G. T. Rogers, 1976, Biochimica et biophysica acta.

A monoclonal antibody against a CEA-related antigen expressed on HT29 colon tumour cells.

G. T. Rogers, K. Bagshawe, A. Kardana, 1984, European journal of cancer & clinical oncology.

CEA-like activity in normal colon tissue.

G. T. Rogers, P. Keep, 1980, European journal of cancer.

Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compounds.

C. Springer, G. T. Rogers, K. Bagshawe, 1991, European journal of cancer.

Galactosylated antibodies and antibody‐enzyme conjugates in antibody‐directed enzyme prodrug therapy

C. Springer, S. Sharma, G. T. Rogers, 1994, Cancer.

Relationship between tumour size and uptake of radiolabelled anti-CEA in a colon tumour xenograft

G. T. Rogers, R. Pedley, P. Keep, 2004, European Journal of Nuclear Medicine.

The value of immunohistochemical markers in the diagnosis of cervical neoplasia

J. Taylor‐Papadimitriou, G. T. Rogers, O. Husain, 1984, British journal of obstetrics and gynaecology.

G. T. Rogers, P. Keep, A. Gibbons, 1995, Environmental Health Perspectives.

Antigenic expression of heat-stable and heat-labile binding sites on carcinoembryonic antigen.

G. T. Rogers, P. Keep, A. Gibbons, 1985, British Journal of Cancer.